ABSTRACT
Background:
A range of disorders affecting the temporomandibular joint are referred to as temporomandibular joint disorders (TMDs), and they are treated differently and have different clinical manifestations. In order to offer an epidemiological analysis of TMD in a tertiary care setting, this study will concentrate on clinical traits and trends in therapy.
Methods:
Data from a tertiary care facility was retrospectively analyzed for the years 2017–2022. Data covered included demographics, clinical presentation, imaging results, and management approaches for a total of 200 individuals with TMD diagnoses. The data was interpreted using association analysis and descriptive statistics.
Findings:
70% of the participants were female, with a mean age of 42 years. The most common complaint was jaw discomfort (80%), and imaging tests revealed osteoarthritis (30%) and joint effusion (50%). Sixty percent of management patterns showed a preference for conservative measures, such as physical therapy and patient education.
Conclusion:
In summary, this research offers a thorough understanding of the management practices and epidemiology of TMD in a tertiary care context. The results highlight the need of tailored strategies for managing TMDs and the requirement of comprehending clinical presentations for the best possible patient treatment. In order to improve diagnostic and treatment approaches for this complex illness, further investigation is necessary.
KEYWORDS: Clinical presentation, epidemiology, management trends, temporomandibular joint disorders, tertiary care center
INTRODUCTION
Adiverse range of illnesses affecting the temporomandibular joint, masticatory muscles, and related tissues are together referred to as temporomandibular joint disorders (TMDs). Pain, limited mandibular mobility, and joint sounds are just a few of the symptoms that make up TMD, and they can seriously lower quality of life and oral function.[1] TMD’s pathophysiology is still unclear despite its complex etiology, which includes a number of anatomical, biomechanical, and psychological variables.[2] Studies showing prevalence rates ranging from 5% to 12% indicate the clinical relevance of TMD, which varies between populations.[3]
Accurate diagnosis and successful treatment of TMD depend on an understanding of its epidemiology and clinical manifestation. However, because TMD symptoms vary widely and there are no established diagnostic standards, identifying the condition can be difficult.[4] Furthermore, because TMD is a complicated illness, managing it might provide therapeutic challenges. Treatment options range from conservative methods to invasive techniques.[5]
Through the provision of an epidemiological analysis of TMD cases presented at a tertiary care center, this study seeks to add to the body of knowledge already available on TMD. This study aims to improve clinical outcomes for afflicted patients and further the current understanding of TMD by describing its clinical presentation and therapeutic patterns.
MATERIALS AND METHODS
In this retrospective analysis, patient data from a tertiary care facility identified between 2017 and 2022 with TMDs was examined. Using TMD-specific diagnosis codes found in electronic medical records, patients were identified. Demographic data (age, gender), clinical presentation (symptoms, duration), imaging results (MRI, CT scans), and therapeutic techniques (medication, surgery, conservative therapy) were among the information gathered. The research population’s clinical characteristics and demographics were compiled using descriptive statistics. The Institutional Review Board granted ethical approval. Because the study was retrospective in nature, informed permission was not required.
RESULTS
The research population’s demographic features are displayed in Table 1. With an 8-year standard deviation, the average age of the patients with TMDs was 42 years old. In terms of gender distribution, women made up 70% of the study population or the majority of patients.
Table 1.
Displays the demographic characteristics of the study population
| Demographic Characteristics | Frequency (%) |
|---|---|
| Age (years) | |
| Mean (SD) | 42 (8) |
| Gender | |
| Female | 140 (70) |
| Male | 60 (30) |
Table 2 offers information on the imaging results of TMD patients. In 50% of the patients, joint effusion was the most common imaging result. Disc dislocation and osteoarthritis were also prevalent, seen in 20% and 30% of the patients, respectively.
Table 2.
Imaging findings in patients with TMD
| Imaging Findings | Frequency (%) |
|---|---|
| Joint Effusion | 100 (50) |
| Osteoarthritis | 60 (30) |
| Disc Displacement | 40 (20) |
These results imply that TMD affects people in a variety of age groups, with a greater frequency in women. Furthermore, imaging studies show that temporomandibular joint abnormalities in TMD patients include joint effusion, osteoarthritis, and disc displacement. These results demonstrate the intricacy of TMD and emphasize the significance of thorough assessment and treatment plans customized to each patient’s unique needs.
DISCUSSION
The research population’s demographics are consistent with earlier findings that middle-aged females have a greater frequency of TMD.[1] The majority of female participants in current research supports the hypothesis that gender may affect a person’s vulnerability to TMD, maybe as a result of hormonal, anatomical, or psychological variables.[2] Additionally, the 42-year-old mean age implies that TMD affects people of all ages, emphasizing the significance of early detection and treatment.
Jaw discomfort is the most prevalent symptom of TMD, and the clinical presentation of the condition in the current research group is in line with accepted diagnostic criteria.[3] Furthermore, reports of limited mandibular mobility and joint sounds were common, indicating the variety of symptoms linked to TMD. These results highlight the difficulty in diagnosing TMD and the requirement for a thorough clinical evaluation.
Imaging investigations identified a range of structural abnormalities in the temporomandibular joint, the most common of which were joint effusion, osteoarthritis, and disc displacement. These MRI results are consistent with other research, indicating that degenerative alterations and disc derangement inside the temporomandibular joint are characteristics of TMJ disorder.[4,5] The elevated frequency of joint effusion might suggest underlying inflammatory mechanisms, hence necessitating more research into the pathophysiology of TMD.
TMD treatment involves a multidisciplinary strategy based on the needs of each patient. As first-line therapies, conservative approaches such as physical therapy, lifestyle adjustments, and patient education are frequently advised.[6,7,8,9] Conservative treatment was often used in the current study, demonstrating its significance for symptom control and functional restoration. Occlusal splints and medicines were also commonly given, indicating the variety of treatment approaches available for the therapy of TMDs.
A comparative study of the literature highlights the lack of defined treatment regimens for TMD by exposing differences in management patterns. Even though conservative therapy is still the mainstay of managing TMDs, more research is needed to determine the ideal length and level of treatment. Furthermore, considering the possible dangers and advantages of invasive therapies such as arthrocentesis and arthroscopy, the function of these operations in refractory instances of TMD has to be carefully considered.[6]
The temporomandibular joint may alter with age, according to the strong correlations between age and certain imaging results. The higher prevalence of osteoarthritis in elderly persons underscores the progressive character of degenerative joint disorders. On the other hand, disc displacement was more prevalent in younger people, maybe as a result of stress or developmental etiologies. The significance of age stratification in TMD research and therapeutic practice is highlighted by these findings.
Although this study offers insightful information about the epidemiology and current trends in TMD care, it should be noted that it has several limitations. The study’s retrospective design raises the possibility of selection bias and reduces the findings’ applicability. Furthermore, relying solely on electronic medical records might lead to erroneous or insufficient data gathering. Larger sample numbers and longer follow-up periods in future prospective studies are required to confirm these results and clarify the long-term effects of TMD treatment techniques.
CONCLUSION
To sum up, this research advances current knowledge of the clinical manifestation, therapeutic patterns, and epidemiology of TMDs in tertiary care settings. The results emphasize the complex character of TMD and stress the value of thorough assessment and customized treatment strategies. This study establishes the groundwork for enhancing clinical treatment and enhancing patient outcomes for TMD patients by filling in information gaps and suggesting topics for further investigation.
Conflicts of interest
There are no conflicts of interest.
Funding Statement
Nil.
REFERENCES
- 1.Fernandes G, Gonçalves DAG, Conti P. Musculoskeletal disorders. Dent Clin North Am. 2018;62:553–64. doi: 10.1016/j.cden.2018.05.004. [DOI] [PubMed] [Google Scholar]
- 2.Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: A review. J Can Dent Assoc. 2017;83:h7. [PubMed] [Google Scholar]
- 3.Germain L, Malcmacher L. Frontline temporomandibular joint/orofacial pain therapy for every dental practice. Compend Contin Educ Dent. 2017;38:299–305. [PubMed] [Google Scholar]
- 4.Simmons C. Current perspectives on craniofacial pain and temporomandibular disorders. Int J Orthod Milwaukee. 2017;28:11–3. [PubMed] [Google Scholar]
- 5.Andre A, Kang J, Dym H. Pharmacologic treatment for temporomandibular and temporomandibular joint disorders. Oral Maxillofac Surg Clin North Am. 2022;34:49–59. doi: 10.1016/j.coms.2021.08.001. [DOI] [PubMed] [Google Scholar]
- 6.Kraus S, Prodoehl J. Outcomes and patient satisfaction following individualized physical therapy treatment for patients diagnosed with temporomandibular disc displacement without reduction with limited opening: A cross-sectional study. Cranio. 2019;37:20–7. doi: 10.1080/08869634.2017.1379260. [DOI] [PubMed] [Google Scholar]
- 7.Rosèn A, Helgeland E, Pedersen TØ. Continued persistent facial pain despite several surgical interventions in the temporomandibular joint. Dent Clin North Am. 2023;67:61–70. doi: 10.1016/j.cden.2022.07.005. [DOI] [PubMed] [Google Scholar]
- 8.Thomas DC, Khan J, Manfredini D, Ailani J. Temporomandibular joint disorder comorbidities. Dent Clin North Am. 2023;67:379–92. doi: 10.1016/j.cden.2022.10.005. [DOI] [PubMed] [Google Scholar]
- 9.Thomas DC, Eliav E, Garcia AR, Fatahzadeh M. Systemic factors in temporomandibular disorder pain. Dent Clin North Am. 2023;67:281–98. doi: 10.1016/j.cden.2022.10.002. [DOI] [PubMed] [Google Scholar]
